Palliative treatment in dextro-transposition of the great arteries: Difference between revisions
(New page: {{Dextro-transposition of the great arteries/complete transposition of the great arteries}} '''For patient information click [[Transposition of the great vessels(patient information)|here...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Dextro-transposition of the great arteries/complete transposition of the great arteries}} | {{Dextro-transposition of the great arteries/complete transposition of the great arteries}} | ||
{{Transposition of the great vessels}} | |||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]; {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org] | |||
{{CMG}} | |||
'''Associate | |||
==Overview== | |||
=== Palliative treatment === | === Palliative treatment === | ||
Revision as of 01:27, 11 August 2011
|
Dextro-transposition of the great arteries/complete transposition of the great arteries Microchapters |
|
Differentiating dextro-transposition of the great arteries from other Diseases |
|---|
|
Diagnosis |
|
Transposition of the great vessels Microchapters |
|
Classification |
|---|
|
Differentiating Transposition of the great vessels from other Diseases |
|
Diagnosis |
|
Treatment |
|
Surgery |
|
Case Studies |
|
Palliative treatment in dextro-transposition of the great arteries On the Web |
|
American Roentgen Ray Society Images of Palliative treatment in dextro-transposition of the great arteries |
|
FDA on Palliative treatment in dextro-transposition of the great arteries |
|
CDC on Palliative treatment in dextro-transposition of the great arteries |
|
Palliative treatment in dextro-transposition of the great arteries in the news |
|
Blogs on Palliative treatment in dextro-transposition of the great arteries |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
Overview
Palliative treatment
Critically ill newborns benefit from the infusion of Prostaglanding E1, which is used to prevent closure of the PDA (additional shunt) through which the systemic circulation is provided with a higher level of oxygen.
Balloon atrial septostomy, enlargement of the interatrial communication using a balloon, allowing better atrial-level mixing between the two parallel circulations. The catheter is introduced via femoral venous or umbilical venous approach, and passed into the right atrium, across the oval foramen and into the left atrium (LA) under echocardiographic or angiographic guidance. Once the ballon is in the LA, is inflated and drawned back across the oval foramen, producing a tear of the interatrial septum.
Antibiotics are often used because the patient is invaded with arterial and vein lines, nasogastric tube, urethral catheter, etc, that makes the patient very susceptible to infections.
Diuretics aid in flushing excess fluid from the body, thereby easing strain on the heart.
Cardiac glycosides, used to maintain proper heart rhythm while increasing the strength of each contraction.
Sedatives may be used palliatively to prevent a young child from pulling out any of their lines.
References
Acknowledgements and Initial Contributors to Page
Leida Perez, M.D.
External links
- Diagram at kumc.edu
- Diagram and description at umich.edu
- Overview at pediheart.org
- Royal Children's Hospital, Melbourne
- Mayo Clinic, Arizona - Florida - Minnesota, USA
